Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bayer A G Ord (OP:BAYZF)

49.83 +0.34 (+0.69%)
Delayed Quote Updated: 10:14 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Bayer A G Ord

< Previous 1 2 3 4 5 Next >
News headline image
Morning Brief: Top Financial Stories Dominating on Friday, June 10 ↗
Reuters Rebranded McDonald’s Restaurants To Reopen In Russia 
Via Benzinga
News headline image
US Top Court To Decide On Bayer's Roundup Weedkiller Appeal ↗
 
Via Benzinga
News headline image
Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara ↗
 
Via Benzinga
News headline image
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs ↗
The FDA aims to put the PI3K inhibitor drug class under a more stringent regulatory scope as the inhibitor has demonstrated substantial toxicity. 
Via Benzinga
News headline image
Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia ↗
Eli Lilly And Co (NYSE: LLY) said it would continue to supply drugs to Russia for urgent medical conditions such as cancer and diabetes but will suspend sales of "non-essential medicines." 
Via Benzinga
News headline image
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy ↗
Exelixis Inc (NASDAQ: EXEL) announced results from the final analysis of the second primary endpoint of overall survival (OS) from the phase 3 COSMIC-312 trial of Cabometyx (cabozantinib) plus... 
Via Benzinga
News headline image
Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities ↗
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) expanded its existing strategic collaboration in fibrosis with Bayer AG (OTC: BAYRY). The expanded... 
Via Benzinga
News headline image
Bayer's Nubeqa Shows Prolonged Survival In Late-Stage Prostate Cancer Trial ↗
Bayer AG (OTC: BAYRY) said a combination therapy, including its Nubeqa drug, was shown to prolong the lives of men who have metastatic prostate cancer in a clinical... 
Via Benzinga
News headline image
Microsoft, Bayer Collaborate To Develop Digital Agricultural Tools, Capabilities ↗
Microsoft Corp (NASDAQ: MSFT) and Bayer AG (OTC: BAYRY) (OTC: BAYZF) collaborated on new internet-based products aimed at helping farmers and industries... 
Via Benzinga
News headline image
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration ↗
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related... 
Via Benzinga
News headline image
Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates ↗
Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed... 
Via Benzinga
Topics Earnings
News headline image
Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod ↗
The European Commission (EC) has approved Merck & Co Inc's (NYSE: MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo... 
Via Benzinga
News headline image
Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes ↗
The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid... 
Via Benzinga
News headline image
Why Did Novocure Shares Plunge Today? ↗
Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer... 
Via Benzinga
News headline image
Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer ↗
Exelixis Inc (NASDAQ: EXEL) and Ipsen (OTC: IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (... 
Via Benzinga
News headline image
Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials ↗
Bayer AG’s (OTC: BAYRY) Parkinson’s disease stem cell therapy has officially landed in the clinic, while another treatment for the neurodegenerative... 
Via Benzinga
News headline image
Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals ↗
Bayer AG (OTC: BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the German drugmaker's pipeline... 
Via Benzinga
News headline image
Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters ↗
A U.S. judge rejected Bayer AG’s (OTC: BAYRY) plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer, saying that... 
Via Benzinga
News headline image
Artificial Intelligence Doctor App Ada Health Closes $90M Funding Led By Bayer, Samsung ↗
German digital health firm Ada Health has raised a $90 million funding round at an undisclosed valuation bringing total investment in the company up to around $150... 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.